DEFA14A ·Filed Apr 1, 2026

VKTX

Viking Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed6mo ago SEC0001193125-26-137924
Proxy solicitation materials
Actionable Insight • Neutral

No trading implications from this filing. Monitor for any unexpected director changes or auditor issues, but this appears to be a standard annual meeting with no surprises.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
VKTX ▲ +12.10% at T+60d
NEUTRAL call ✓ call won +12.10% · α vs SPY -2.06% · entry $34.80 → $39.01
Entry anchored
Apr 1, 03:59 PM ET
via exchange tick
T+1d
-2.50%
call -2.50% · α -2.98%
$33.93
settled 6mo ago
T+5d
-1.55%
call -1.55% · α -5.17%
$34.26
settled 6mo ago
T+20d
-10.40%
call -10.40% · α -20.28%
$31.18
settled 5mo ago
T+60d
+12.10%
call +12.10% · α -2.06%
$39.01
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Viking Therapeutics is holding its 2026 annual shareholder meeting to vote on director elections, auditor selection, and executive compensation. This is a routine annual filing with no material financial or operational updates.

Key Facts

  • Annual shareholder meeting scheduled for May 19, 2026
  • Voting on election of two Class II directors: J. Matthew Singleton and S. Kathryn Rouan, Ph.D.
  • Ratification of CBIZ CPAS P.C. as independent auditors
  • Advisory vote on executive compensation
  • Board recommends approval of all proposals

Financial Impact

No immediate financial impact - routine governance matters

governancecompliance

Risk Factors

  • None identified in this filing
  • Standard risks associated with any corporate governance vote

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001193125-26-137924
Document: 0001193125-26-137924-index-headers.html0001193125-26-137924
Document: 0001193125-26-137924-index.html0001193125-26-137924
Document: 0001193125-26-137924.txt0001193125-26-137924
3 reports for VKTX
Performance horizon
Filters
Rows
Reports for VKTX — sortable, filterable
TypeNow
Jul 30, 2026
9w ago
Insider Cluster
NEUTRAL ★ 4/10
$33.11 $33.86▲ +2.27%▼ −1.70%$29.94 (−9.57%)
Jul 30, 2026
9w ago
Insider Cluster
NEUTRAL ★ 3/10
$33.11 $33.86▲ +2.27%▼ −1.70%$29.94 (−9.57%)
Apr 1, 2026
26w ago
DEFA14A
NEUTRAL ★ 2/10
$34.80 $31.18▼ −10.40%▼ −20.28%$29.94 (−13.97%)
Showing 3 of 3

US Market Status

Market Closed — Opens Mon (64h 35m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access